Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Your RPS

Community pharmacy 'a huge opportunity' to detect early lung disease

National lung health report notes the importance of community pharmacy in detection, treatment and prevention of lung diseases.

Anna Murphy

Source: Courtesy of Anna Murphy

Anna Murphy, respiratory clinical spokesperson for the Royal Pharmaceutical Society, said that a formal referral system between community pharmacists and GPs would be a “game-changer for improving patient health”

Community pharmacists should be able to formally refer people with warning signs of lung disease directly to GPs, according to a report from the Taskforce for Lung Health, of which the Royal Pharmaceutical Society (RPS) is one of 29 member organisations.

‘A National Five Year Plan for Lung Health’, which was launched by the task force on 5 December 2018, says that visits to community pharmacy offer “a huge opportunity to pick up on warning signs for lung disease”. The report recommends that community pharmacists be “recognised as valuable healthcare professionals who can identify and support people at risk of developing lung disease or those who are already being treated”.

The RPS is represented on the task force by Heidi Wright, English practice and policy lead at the RPS, and Anna Murphy, consultant respiratory pharmacist and RPS respiratory clinical spokesperson, ensuring that pharmacy was included in the plan’s recommendations.

“A formal referral system to enable [community pharmacists] to refer people directly to general practice would be a game-changer for improving patient health and I warmly welcome this recommendation in the report”, Murphy said.

The report also recommends the expansion of medicines use reviews and the new medicines service, with the removal of caps of the number of such services a pharmacy can carry out.

“A shocking 90% of asthma-related deaths are believed to be preventable with the right treatment and monitoring, and reviews are an important part of this”, Murphy added.

Other recommendations include the provision of more training places for pharmacists in GP surgeries, and the inclusion of consultant pharmacist posts in strategic workforce plans.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205860

Readers' comments (1)

  • Could community pharmacists not refer for a chest x-ray first and then refer to the GP depending on the results?

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.